These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 392085)

  • 1. T lymphocyte subpopulations responsive to alloantigens.
    Bach FH; Alter BJ; Sopori ML
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):587-96. PubMed ID: 392085
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro correlates of in vivo skin graft rejection in Xenopus.
    Lallone RL; Horton JD
    Transplantation; 1985 Feb; 39(2):223-6. PubMed ID: 3881861
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of lymphocyte differentiation antigens on cells responsive to H-2 mutant alloantigens.
    Frelinger JA; Wettstein PJ
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):597-607. PubMed ID: 160453
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell alloreactivity to major histocompatibility complex peptides in context of self major histocompatibility complex.
    Suciu-Foca N; Xi YP; Sun YK; Liu Z
    Transplant Proc; 1993 Feb; 25(1 Pt 1):73-4. PubMed ID: 8438461
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of the MHC antigens in the mature and immature host.
    Gatti RA; Kempner DH; Leibold W
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):803-13. PubMed ID: 315534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossreactive cytotoxic T-cell line expanded by T-cell growth factor.
    Dubey DP; Stux S; Tsong YK; Yunis E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1153-6. PubMed ID: 6791334
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated lympholysis: target susceptibility to lysis correlates with surface major histocompatibility complex expression.
    Suranyi MG; Waugh J; Bishop GA; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):417-20. PubMed ID: 2950620
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell differentiation.
    Miller RG
    Int J Cell Cloning; 1986; 4 Suppl 1():26-38. PubMed ID: 2943826
    [No Abstract]   [Full Text] [Related]  

  • 10. Specific suppression of alloimmune responses by antigen.
    Batchelor JR; Burgos H; Welsh KI
    Transplant Proc; 1979 Mar; 11(1):973-7. PubMed ID: 377733
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of in vitro natural cytotoxicity of horse lymphocytes against sarcoid-derived tumor cells not expressing major histocompatibility complex antigens.
    Broström H; Troye-Bomberg M; Perlmann P
    Am J Vet Res; 1996 Jul; 57(7):992-9. PubMed ID: 8807009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The control of the immune response.
    Asherson GL
    Ann Allergy; 1984 Dec; 53(6 Pt 2):557-62. PubMed ID: 6209999
    [No Abstract]   [Full Text] [Related]  

  • 13. Memory T cells express high levels of a novel leukocyte common antigen epitope identified by the A6 MAb.
    Aversa GG; Hall BM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):300-1. PubMed ID: 1703685
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients.
    Quinnan GV; Kirmani N; Esber E; Saral R; Manischewitz JF; Rogers JL; Rook AH; Santos GW; Burns WH
    J Immunol; 1981 May; 126(5):2036-41. PubMed ID: 6260861
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different biology and pathology of minor alloantigen-specific cytotoxic and proliferative T cells.
    van Els C; Bakker A; van Rood J; Goulmy E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):429-30. PubMed ID: 1990577
    [No Abstract]   [Full Text] [Related]  

  • 18. T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2I region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset.
    Smith DM; McKisic M; Stuart FP; Fitch FW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):162-4. PubMed ID: 2650100
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure and function of HLA molecules.
    Thorsby E
    Transplant Proc; 1987 Feb; 19(1 Pt 1):29-35. PubMed ID: 3493554
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell responses to alloantigens. IV. In vivo and in vitro studies of the abrogation of presensitization to major histocompatibility antigens.
    Burton RC; Fortin JL; Aversano RC; Russell PS
    Transplantation; 1982 Apr; 33(4):339-46. PubMed ID: 7041359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.